Immunic, Inc.

IMUX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001280776

SEC filings (opens in a new tab)

No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Immunic, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of IMUX: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Of which not filed for Q1 2026	Q1 2026	Change
Holders	60	1	78	+19
Shares	51.3M	5.02M	64.9M	+18.7M (+40.4%)
Value	$28.3M	$2.68M	$72.1M	+$46.5M (+181.7%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Immunic, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to IMUX in Q1 2026
Institution	Shares	Value	% of portfolio
Vanguard Capital Management LLC	5,138,316	$5.70M	0.00%
Soleus Capital Management, L.P.	4,500,000	$5.00M	0.20%
683 Capital Management, LLC	2,450,000	$2.72M	0.25%
Propel Bio Management, LLC	2,344,779	$2.62M	1.65%
Woodline Partners LP	967,152	$1.07M	0.00%
Renaissance Technologies LLC	919,164	$1.02M	0.00%
Vanguard Fiduciary Trust Co	740,542	$822.0K	0.00%
HRT Financial LP	493,393	$547.0K	0.00%
Simplify Asset Management Inc.	438,932	$487.2K	0.01%
Hudson Bay Capital Management LP	213,017	$236.4K	0.00%
Omers Administration Corp	168,300	$186.8K	0.00%
Goldman Sachs Group Inc	149,770	$166.2K	0.00%
Virtu Financial LLC	113,366	$126.0K	0.01%
Qube Research & Technologies Ltd	111,460	$123.7K	0.00%
MML Investors Services, LLC	90,630	$100.6K	0.00%
Cambridge Investment Research Advisors, Inc.	48,500	$54.0K	0.00%
Brevan Howard Capital Management LP	45,843	$50.9K	0.00%
Graham Capital Management, L.P.	33,297	$37.0K	0.00%
Vanguard Global Advisers, LLC	31,867	$35.4K	0.00%
Quadrature Capital Ltd	29,627	$32.9K	0.00%
Schonfeld Strategic Advisors LLC	28,300	$31.4K	0.00%
Scientech Research LLC	26,635	$29.6K	0.02%
CTC Alternative Strategies, Ltd.	24,390	$27.1K	0.06%
CI Private Wealth, LLC	22,100	$24.5K	0.00%
Lincoln Capital Corp	20,400	$22.6K	0.01%
Advisor Group Holdings, Inc.	20,000	$22.2K	0.00%
Axq Capital, LP	18,151	$20.1K	0.00%
Commonwealth Equity Services, LLC	10,360	$11.5K	0.00%
Baader Bank INC	11,281	$8.22K	0.00%
Group One Trading, L.P.	1,702	$1.89K	0.00%
FMR LLC	455	$505	0.00%
Caitong International Asset Management Co., Ltd	3	$3	0.00%
ADAR1 Capital Management, LLC	30,000	$0	0.00%

Sold out (14)

Institutions that held Immunic, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of IMUX in Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Colony Group, LLC	2,622,462	$2.29M
Gsa Capital Partners LLP	527,455	$282.0K
Squarepoint Ops LLC	352,875	$188.3K
Connective Capital Management, LLC	301,296	$160.8K
Seven Fleet Capital Management LP	155,223	$82.8K
Boothbay Fund Management, LLC	130,585	$69.7K
Bridgeway Capital Management, LLC	40,000	$21.3K
Marex Group plc	32,700	$17.5K
StoneX Group Inc.	20,540	$11.0K
Level Four Advisory Services, LLC	10,780	$5.75K
PFG Investments, LLC	10,500	$5.60K
Retirement Planning Group	10,417	$5.56K
Addison Advisors LLC	5,200	$2.78K
Allworth Financial LP	842	$450

Not filed for Q1 2026 yet (1)

Institutions that held Immunic, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMUX in Q4 2025 that haven't filed for Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Vanguard Group Inc	5,020,337	$2.68M